JP2002082047A - Urinalysis device - Google Patents

Urinalysis device

Info

Publication number
JP2002082047A
JP2002082047A JP2000272803A JP2000272803A JP2002082047A JP 2002082047 A JP2002082047 A JP 2002082047A JP 2000272803 A JP2000272803 A JP 2000272803A JP 2000272803 A JP2000272803 A JP 2000272803A JP 2002082047 A JP2002082047 A JP 2002082047A
Authority
JP
Japan
Prior art keywords
urine
optical rotation
rotation angle
light
test apparatus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000272803A
Other languages
Japanese (ja)
Other versions
JP4507373B2 (en
Inventor
Tadashi Miki
匡 三木
Hirohisa Imai
博久 今井
Sanenori Ueda
実紀 上田
Hisaaki Miyaji
寿明 宮地
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Priority to JP2000272803A priority Critical patent/JP4507373B2/en
Publication of JP2002082047A publication Critical patent/JP2002082047A/en
Application granted granted Critical
Publication of JP4507373B2 publication Critical patent/JP4507373B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To enhance the accuracy of determining a urine sugar level by detecting the influences of optically active substances other than sugars, without use of additional light sources and optical components. SOLUTION: An optical rotation angle A which appears is calculated by an optical rotation angle detecting means 6 from the amount of light emitted from a light emitting means 1 and then propagating through urine in a urine reservoir portion 4 and received by a light receiving means 5, and a control means 1 compares the optical rotation angle A to a threshold; if the angle is less than the threshold or assumes a negative value, measurements are invalidated.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、人をはじめとする
動物から採取した尿中のグルコース濃度である尿糖値な
どの尿中成分の測定方法および測定装置に関するもので
ある。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method and apparatus for measuring urinary components such as urinary glucose, which is the concentration of glucose in urine collected from animals including humans.

【0002】[0002]

【従来の技術】尿糖値などの尿中成分の濃度は、健康状
態の一部を反映している。そこで、容易にこれらを測定
する方法が求められている。
2. Description of the Related Art The concentration of urinary components such as urine sugar level reflects a part of a health condition. Therefore, there is a need for a method of easily measuring these.

【0003】従来、尿検査は、糖、蛋白質等、個々の検
査項目に応じた試薬を含浸した試験紙を尿に浸し、これ
の呈色反応を分光測定機等によって観測することにより
行われていた。この方法によると、1回の検査項目ごと
に新たな試験紙が必要であるため、ランニングコストが
高く、さらに省力化のための自動化にも限界がある。
Conventionally, urinalysis is performed by immersing a test paper impregnated with a reagent corresponding to each test item such as sugar or protein in urine, and observing the color reaction of the test paper with a spectrophotometer or the like. Was. According to this method, since a new test paper is required for each inspection item, the running cost is high, and there is a limit to automation for labor saving.

【0004】すなわち、試験紙が家庭において使用され
る場合は、素人に試験紙の設定及び交換を要求すること
になる。この作業が、比較的嫌われることが、尿検査装
置の家庭への普及を妨げていると考えられていた。
That is, when test papers are used at home, the layman is required to set and replace the test papers. It was thought that the relative dislike of this work hindered the spread of urine analyzers to homes.

【0005】これに対して、試験紙など消耗品を必要と
しない尿検査方法が提案されている。この尿検査方法で
は、尿中の代表的な糖成分であるグルコースが旋光度を
示すのに着目して、尿の旋光度を測定する原理によっ
て、尿中のグルコース濃度を求めている。
On the other hand, a urine test method which does not require consumables such as test papers has been proposed. In this urine test method, the glucose concentration in urine is determined based on the principle of measuring the optical rotation of urine, focusing on the fact that glucose, which is a typical sugar component in urine, exhibits optical rotation.

【0006】この原理によると、旋光性物質を含む液体
に光を伝播させると、旋光性物資の濃度に対して光の偏
光方向が回転する。すなわち、(式1)が満たされる。
According to this principle, when light is propagated through a liquid containing a rotatory substance, the polarization direction of the light rotates with respect to the concentration of the rotatory substance. That is, (Equation 1) is satisfied.

【0007】A=L×α×C (式1) 但し、L:測定光路長 A:旋光度[度] α:旋光性物質の比旋光度 C:物質濃度 例えば濃度が100mg/dlのグルコース水溶液中を波長
589nmの光が100mm伝播すると、光の偏光方向
は約0.05度回転する。
A = L × α × C (Equation 1) where L: measured optical path length A: optical rotation [degree] α: specific rotation of the optically rotating substance C: substance concentration For example, an aqueous glucose solution having a concentration of 100 mg / dl. When light having a wavelength of 589 nm propagates through the inside by 100 mm, the polarization direction of the light rotates about 0.05 degrees.

【0008】次に、液体中に旋光性物質がN種類含まれ
る場合には、(式2)のようになる。
Next, when N kinds of optically active substances are contained in the liquid, the following equation (2) is obtained.

【0009】 A=L×(α1×C1+α2×C2+・・・・+αN×CN) (式2) 但し、L:測定光路長 A:旋光度[度] αn:物質n(但し、nは1〜Nの自然数)の比旋光度 Cn:物質nの濃度 (式2)より明らかなように、例えば、尿の場合には、
得られた旋光度にグルコースにより発現する旋光角度と
蛋白質等のグルコース以外の旋光性物質によりは告げん
する旋光角度の和が含まれる。
A = L × (α1 × C1 + α2 × C2 +... + ΑN × CN) (Equation 2) where L: measured optical path length A: optical rotation [degree] αn: substance n (where n is 1 to Specific rotation of natural number N) Cn: Concentration of substance n As is clear from (Equation 2), for example, in the case of urine,
The obtained optical rotation includes the sum of the optical rotation angle expressed by glucose and the optical rotation angle reported by an optically rotating substance other than glucose such as protein.

【0010】尿中に排泄されうる糖以外の代表的な旋光
性物質としては、蛋白質の一種であるアルブミンや、ア
ミノ酸の一種であるヒスチジン等がある。通常、アルブ
ミンの尿中への排泄量は、グルコースより更に少なく、
およそ6mg/dl以下である。一般には、従来の尿糖値の
測定結果は、50〜100mg/dlごとに区切った−、
±、+などの区画表示記号で報知する場合が一般的であ
り、こうした糖以外の旋光性物質による旋光は、通常の
排泄濃度では、この区画表示にはズレを及ぼさない場合
がほとんどである。
Representative optically active substances other than sugars excretable in urine include albumin, a kind of protein, and histidine, a kind of amino acid. Usually, the amount of albumin excreted in urine is even less than that of glucose,
It is about 6 mg / dl or less. In general, the conventional measurement results of urine sugar level are divided into 50 to 100 mg / dl,
In general, the information is notified by a section display symbol such as ± or +. In most cases, the rotation caused by the optically active substance other than the sugar does not shift the section display at a normal excretion concentration.

【0011】[0011]

【発明が解決しようとする課題】しかし、腎臓疾患を有
する患者の尿アルブミン値は、100mg/dl以上、すな
わち通常値に対して10倍以上になることもある。ま
た、ヒスチジンも通常は数mg/dl以下であるが、一部の
代謝疾患や肉類などの過剰摂取により尿中へ多量に排泄
される場合がある。こうしたアルブミンやヒスチジンな
どの尿中への異常排泄時には、判定精度が落ちて尿糖値
の区画表示にズレを起こす場合がある。
However, the urinary albumin level in patients with renal disease may be 100 mg / dl or more, that is, more than 10 times the normal value. In addition, histidine is usually several mg / dl or less, but may be excreted in a large amount in urine due to some metabolic diseases or excessive intake of meat and the like. At the time of abnormal excretion of such albumin and histidine into the urine, the accuracy of the determination may be reduced and the display of the urine glucose level may be shifted.

【0012】このような糖以外の旋光性物質による旋光
の発現を補正する方式としては、比旋光度が伝播させる
光の波長ごとに異なることを利用して、複数の波長にお
ける旋光角度を測定し、測定した波長ごとに(式2)に
相当する連立方程式を立てて、これらを解くことによっ
て各旋光性物質の濃度を算出する多波長式(例えば特開
平9−138231号公報)や、加熱した場合の濁り具
合を光の散乱や透過光量の減衰度合いで検出して蛋白質
濃度に換算し計測した旋光角度から差し引く加熱式(例
えば特開平10−142223号公報)などが提案され
ている。
As a method of correcting the appearance of optical rotation due to the optical rotation substance other than the sugar, the optical rotation angle at a plurality of wavelengths is measured by utilizing the fact that the specific optical rotation differs for each wavelength of light to be propagated. A simultaneous equation corresponding to (Equation 2) is established for each measured wavelength, and a multi-wavelength equation (for example, JP-A-9-138231) for calculating the concentration of each optically active substance by solving these equations, A heating method (for example, Japanese Patent Application Laid-Open No. H10-142223) has been proposed in which the degree of turbidity is detected based on the degree of light scattering or the amount of attenuation of transmitted light, converted into a protein concentration, and subtracted from the measured optical rotation angle.

【0013】しかし、これらの方法では複数の波長を照
射させるための複数の光源や光学部品、加熱に要するヒ
ータなどの追加部品が必要となる課題がある。
However, these methods have a problem in that additional components such as a plurality of light sources and optical components for irradiating a plurality of wavelengths and a heater required for heating are required.

【0014】本発明はこのような従来の課題を解決する
ものであり、簡単な構成で尿中への旋光性物質の異常な
排泄を判断して、判定結果を無効とすることにより尿糖
値の判定精度を向上させた尿検査装置を提供することを
目的とするものである。
The present invention solves such a conventional problem, and determines the abnormal excretion of the optical rotatory substance into urine with a simple configuration, and invalidates the result of determination to thereby determine the urinary sugar level. It is an object of the present invention to provide a urine test apparatus in which the determination accuracy is improved.

【0015】[0015]

【課題を解決するための手段】上記課題を解決するため
に本発明は、尿中を伝播した際に生じた旋光角度が、予
め設定した閾値以下または負値となる場合に、該測定結
果を無効とする判定機構を設けたものである。上記判定
機構によって、代謝疾患や、疲労時や食事内容による一
時的な尿中への異常排泄による尿糖値の判定精度を向上
させることができる。
In order to solve the above-mentioned problems, the present invention provides a method for measuring the angle of rotation generated when the light is propagated in urine is smaller than a predetermined threshold value or a negative value. It is provided with a determination mechanism for invalidation. With the above-described determination mechanism, it is possible to improve the determination accuracy of a urinary sugar level due to abnormal abnormal excretion in urine due to a metabolic disease, fatigue, or meal contents.

【0016】[0016]

【発明の実施の形態】上記の課題を解決するために請求
項1の発明は、尿中を伝播した際に生じた旋光角度が、
予め設定した閾値以下または負値となる場合に、該測定
結果を無効とする判定機構を設けたものである。上記判
定機構によって、代謝疾患や、疲労時や食事内容による
一時的な尿中への異常排泄による尿糖値の判定精度を向
上させることができる。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In order to solve the above-mentioned problems, the invention according to claim 1 is characterized in that the angle of rotation generated when propagating in urine is:
A determination mechanism is provided that invalidates the measurement result when the value is equal to or less than a predetermined threshold value or a negative value. With the above-described determination mechanism, it is possible to improve the determination accuracy of a urinary sugar level due to abnormal abnormal excretion in urine due to a metabolic disease, fatigue, or meal contents.

【0017】また請求項2の発明は、予め設定した閾値
として、尿中の旋光性物質の平均濃度で発現する旋光角
度の合算値として算出した旋光角度を設定することによ
り判定の精度をより向上させたものである。
According to a second aspect of the present invention, the accuracy of the determination is further improved by setting, as a preset threshold value, an optical rotation angle calculated as a sum of optical rotation angles that are expressed by the average concentration of the optical rotation substance in urine. It was made.

【0018】また請求項3の発明は、男女、年齢、体格
などの個人差により予め決めた閾値を変更することによ
り、個人差に応じて最適な判定ができるようにしたもの
である。
In the invention according to claim 3, an optimum judgment can be made according to individual differences by changing a predetermined threshold value according to individual differences such as gender, age, and physique.

【0019】また請求項4の発明は、伝播させる光の波
長として、糖とそれ以外の旋光性物質の比旋光度の差が
比較的大きく、かつ汎用のレーザ光源を適用できる90
0nm以下の波長を選ぶことにより、より判定の精度を
向上させ、かつ商業上でもメリットのある構成が実現で
きるようにしたものである。
According to the fourth aspect of the present invention, the difference in specific rotation between sugar and other optically active substances is relatively large as the wavelength of light to be propagated, and a general-purpose laser light source can be used.
By selecting a wavelength of 0 nm or less, the accuracy of determination can be further improved, and a configuration that is commercially advantageous can be realized.

【0020】請求項5の発明は、旋光角度の測定を、磁
気的零位法で構成したものので、組立誤差が生じにく
い。
According to the fifth aspect of the present invention, since the optical rotation angle is measured by the magnetic null method, an assembly error hardly occurs.

【0021】請求項6の発明は、旋光角度の測定を、光
学的零位法で構成したもので、より小型化を図ることが
できる。
According to the sixth aspect of the present invention, the optical rotation angle is measured by an optical null method, and the size can be further reduced.

【0022】請求項7の発明は、報知手段を設け、判定
結果を無効とした場合に、前記報知手段により再測定を
促すようにしたもので、より判定精度を向上できる。
According to a seventh aspect of the present invention, the notifying means is provided, and when the judgment result is invalidated, the notifying means prompts the re-measurement, so that the judgment accuracy can be further improved.

【0023】[0023]

【実施例】以下本発明の実施例について図1から図4を
参照して説明する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS An embodiment of the present invention will be described below with reference to FIGS.

【0024】(実施例1)実施例1を図1から図3を参
照して説明する。図1の1は、尿検査装置全体を制御す
る制御手段でマイコンやその周辺回路から構成する。ま
た2は、判定結果を報知する、例えば液晶表示板やユー
ザが検査の開始を指示するスイッチなどを備えた報知手
段、3はレーザ光源などの光学部品や発光回路等からな
る発光手段、4は試料となる尿を貯える尿溜め部、5は
フォトダイオードなどの光学部品や受光回路等からなる
受光手段、6は旋光角度検出手段である。
(Embodiment 1) Embodiment 1 will be described with reference to FIGS. Reference numeral 1 in FIG. 1 denotes control means for controlling the entire urine test apparatus, which is composed of a microcomputer and its peripheral circuits. Reference numeral 2 denotes a notifying unit for notifying a determination result, for example, a liquid crystal display panel or a switch provided by a user for instructing a start of an inspection. A urine reservoir section for storing urine serving as a sample, 5 is a light receiving means including an optical component such as a photodiode or a light receiving circuit, and 6 is a rotation angle detecting means.

【0025】図3は、図1の尿検査装置を、磁気的零位
法で構成する場合のブロック図である。図3の31〜3
3は破線3で囲んだ発光手段3の構成要素を示す一例で
あり、31はレーザ光源、33はレーザ光源31を点灯
させる発光回路、32はレーザ光源31から光の成分の
内、特定方向の偏光成分のみを通過させる偏光フィルタ
であり、ここでは垂直方向の偏光成分を通過させるよう
に配置する。図3の51〜54は破線で囲んだ発光手段
5の構成要素を示す一例であり、51は尿を伝播した光
を受光するフォトダイオード、52は特定の偏光方向の
成分のみを通過させる検光フィルタであり、発光手段3
内の偏光フィルタ32と互いに直交した水平方向の偏光
成分のみ通過するように配置する。54は尿溜め部4の
尿を伝播した光に磁場を印加するファラデーコイルであ
り、例えば空心材にエナメル線を巻き、内部に水などの
媒質をガラス板などで封入して構成する。53はフォト
ダイオード51の光量に応じた信号出力を電圧値に変換
および増幅して制御手段1に入力する受光回路である。
FIG. 3 is a block diagram in the case where the urine test apparatus of FIG. 1 is configured by a magnetic null method. 3 to 3 in FIG.
3 is an example showing the components of the light emitting means 3 surrounded by a broken line 3, 31 is a laser light source, 33 is a light emitting circuit for turning on the laser light source 31, 32 is a light component from the laser light source 31 in a specific direction. This is a polarizing filter that allows only a polarized light component to pass, and is arranged so as to pass a polarized light component in the vertical direction. Reference numerals 51 to 54 in FIG. 3 denote examples of components of the light emitting means 5 surrounded by a broken line, 51 denotes a photodiode for receiving light transmitted through urine, and 52 denotes an analysis for passing only a component in a specific polarization direction. Light emitting means 3 which is a filter
Are arranged so as to pass only horizontal polarization components orthogonal to the polarization filter 32 inside. Numeral 54 denotes a Faraday coil for applying a magnetic field to the light propagating in the urine of the urine reservoir 4, which is formed by winding an enamel wire around an air core material and enclosing a medium such as water in a glass plate or the like. Reference numeral 53 denotes a light receiving circuit which converts and amplifies a signal output corresponding to the light amount of the photodiode 51 into a voltage value and inputs the voltage value to the control means 1.

【0026】61はファラデーコイル54に流す電流量
を調整して印加する磁場強度を変える電流回路であり、
本実施例では、以下に説明する動作で旋光角度を検出す
る。
Reference numeral 61 denotes a current circuit for adjusting the amount of current flowing through the Faraday coil 54 to change the intensity of the applied magnetic field.
In the present embodiment, the optical rotation angle is detected by the operation described below.

【0027】媒質中に光を伝播させ、その伝播方向に磁
場を印加すると、光の偏光方向が伝播に従って回転す
る。この現象を光ファラデー効果と呼んでいる。この光
ファラデー効果は、(式3)で表される。
When light is propagated through a medium and a magnetic field is applied in the direction of propagation, the polarization direction of the light rotates according to the propagation. This phenomenon is called the optical Faraday effect. This optical Faraday effect is represented by (Equation 3).

【0028】a=V×H×L (式3) ここで、 a:偏光方向の回転角度[度] V:媒質のベルデ定数[度/A] H:磁場[A/m] L:伝播距離[m] (式3)の磁場Hは、ファラデーコイルのエナメル線の
巻き数nと、電流回路61がファラデーコイル54に流
す電流量Iの積(n×I)に比例する。従って、電流量
Iを変化させて(式3)で示す光ファラデー効果により
発現する旋光角度aを変化させると、この旋光角度aと
(式2)に示す尿中の旋光性物質によって発現する旋光
角度Aとが丁度キャンセルしあった場合に、受光回路5
3の受光量が最小となる消光点が現れる。この消光点で
の電流量Iから旋光角度Aが算出できるものである。
A = V × H × L (Equation 3) where: a: rotation angle of polarization direction [degree] V: Verdet constant of medium [degree / A] H: magnetic field [A / m] L: propagation distance [M] The magnetic field H in (Equation 3) is proportional to the product (n × I) of the number n of turns of the enameled wire of the Faraday coil and the amount of current I flowing through the Faraday coil 54 by the current circuit 61. Therefore, when the amount of current I is changed to change the angle of rotation a generated by the optical Faraday effect expressed by (Equation 3), the angle of rotation a and the optical rotation expressed by the optically rotating substance in urine shown by (Equation 2) When the angle A is just canceled, the light receiving circuit 5
An extinction point at which the amount of received light of No. 3 becomes minimum appears. The rotation angle A can be calculated from the current amount I at the extinction point.

【0029】以上の磁気的零位法により測定された旋光
角度Aは、糖以外の旋光性物質が存在する場合には、
(式2)に示したとおり、各旋光物質により発現した旋
光角度の和となっている。今、旋光性物質として、糖と
してのグルコースと蛋白質としてのアルブミンだけが存
在する場合を考える。グルコースの比旋光度をαg、ア
ルブミンの旋光角度―αa(αaは正値)とすると、
(式2)は(式4)のように簡略化して書き換えること
ができる。
The optical rotation angle A measured by the magnetic null method described above is as follows when an optical rotation substance other than sugar is present.
As shown in (Equation 2), it is the sum of the optical rotation angles developed by each optical rotation substance. Now, consider a case where only glucose as a sugar and albumin as a protein are present as optical rotatory substances. Assuming that the specific rotation of glucose is αg and the optical rotation angle of albumin−αa (αa is a positive value),
(Equation 2) can be simplified and rewritten as (Equation 4).

【0030】 A=L×(αg×Cg−αa×Ca) (式4) 従って、(式4)での旋光角度Aが負値となるのは、グ
ルコース濃度Cgよりもアルブミン濃度Caが多量に尿
中に排泄されているケースであると考えられ、つまり、
糖以外の旋光性物質が異常に尿中に排泄されており、尿
糖値を算出するには不適なケースと判定できるものであ
る。
A = L × (αg × Cg−αa × Ca) (Equation 4) Therefore, the reason why the optical rotation angle A in (Equation 4) is a negative value is that the albumin concentration Ca is larger than the glucose concentration Cg. This is considered to be the case excreted in urine,
The optical rotatory substance other than sugar is abnormally excreted in urine, which can be determined to be inappropriate for calculating the urinary sugar level.

【0031】一例として図2にある母集団で実際に尿検
査を行った場合の尿蛋白質と尿糖の検査結果を示してお
り、縦左端欄は、尿糖濃度の区分を示しており、(−)
(±)などの記号は区画表示記号、100〜249など
の数字は該区画の濃度範囲でありmg/dl単位、中央値は
この濃度範囲の中央の濃度を代表値として示している。
また横上端欄は同じく尿蛋白質濃度の区分を表してい
る。図中の、実線または破線で囲んだ領域A〜領域Cに
記した数字(%)は、本母集団での全人数に対する人数
比率である。領域Aは、尿糖値が陰性とされる区画の領
域であり、領域BおよびCは尿糖値が陽性とされる区画
の領域である。この内、区画Cは一例として、糖の比旋
光度αgと蛋白質の比旋光度αaを等しいとして、単純
に尿糖濃度Cgおよび尿蛋白質濃度Caを各区画の中央
値として、(式4)に当てはめて計算すれば、旋光角度
Aは負値となり尿糖が検出されない陰性であるとして判
定されるケースが考えられる領域である。しかし、本実
施例では、旋光角度Aは負値となることから、この領域
Cを蛋白質が異常に排泄されていると判定して測定結果
を廃棄することにより、こうしたケースでの尿糖濃度の
区画表示のズレを低減できるものである。
As an example, the results of urine protein and urine sugar tests are shown when urinalysis is actually performed on the population shown in FIG. 2, and the leftmost column in the vertical column shows the classification of urine sugar concentration. −)
Symbols such as (±) indicate the section display symbols, numbers such as 100 to 249 indicate the concentration range of the section in units of mg / dl, and the median represents the central concentration in this concentration range as a representative value.
The upper right column also shows the classification of urine protein concentration. In the figure, the numbers (%) described in the areas A to C surrounded by the solid line or the broken line are the ratio of the number of persons to the total number of persons in the present population. The area A is an area of a section where the urine sugar value is negative, and the areas B and C are areas of an area where the urine sugar value is positive. Among these, as an example, assuming that the specific rotation αg of the sugar is equal to the specific rotation αa of the protein, the division C is simply expressed by (Equation 4) assuming that the urine sugar concentration Cg and the urine protein concentration Ca are the median of each division. If the calculation is performed by applying the rotation angle, the optical rotation angle A is a negative value, and it is an area where a case where it is determined that urine sugar is not detected and is determined to be negative is considered. However, in the present embodiment, since the optical rotation angle A is a negative value, it is determined that the protein is abnormally excreted in this region C, and the measurement result is discarded. It is possible to reduce the deviation of the section display.

【0032】最後に、以上の事項に基づいて図3を用い
て動作を説明する。尿溜り部4に尿が充填され、ユーザ
の指示により尿糖検査が開始されると、制御手段1は、
発光回路33によりレーザ光源31を点灯する。レーザ
光源31からの光は、偏光フィルタ32を通過して垂直
偏光方向の成分のみが伝播する。この光は尿溜り部4内
を伝播し、ファラデーコイル54内を伝播し、検光フィ
ルタ52を通過して、フォトダイオード51に入射し、
この際の光量を受光回路53で電圧値に変換して制御手
段51に入力する。この時、検光フィルタ52は尿内の
旋光性物質による旋光により発現した水平偏光成分のみ
を通過させる。
Finally, the operation will be described with reference to FIG. When urine is filled in the urine reservoir 4 and a urine sugar test is started according to a user's instruction, the control means 1
The light emitting circuit 33 turns on the laser light source 31. The light from the laser light source 31 passes through the polarization filter 32, and only the component in the vertical polarization direction propagates. This light propagates through the urine reservoir 4, propagates through the Faraday coil 54, passes through the analysis filter 52, and enters the photodiode 51,
The light quantity at this time is converted into a voltage value by the light receiving circuit 53 and input to the control means 51. At this time, the analysis filter 52 allows only the horizontal polarization component generated by the optical rotation due to the optical rotation substance in the urine to pass.

【0033】制御手段1では、電流回路61によりファ
ラデーコイル51に流す電流を変化させ、受光回路53
での受光量が最小となる消光点を検出し、この時点の電
流量から、尿を伝播する際に発現する旋光角度Aを算出
する。次に、制御手段1は、算出した旋光角度Aが正値
か負値かどうかを判定し、負値の場合には尿中に異常に
蛋白質などの糖以外の旋光性物質が異常に排泄されてい
る旨を報知して、この算出結果を破棄し、正値の場合は
(式1)に従って糖濃度Cgを算出し、0〜100mg/d
lは(−)、100〜150mg/dlは(±)、150〜3
00mg/dl(+)といった区画表示記号に変換して、報
知手段2に表示する。
In the control means 1, the current flowing through the Faraday coil 51 is changed by the current circuit 61, and the light receiving circuit 53 is changed.
Then, the extinction point at which the amount of received light is minimized is detected, and from the current amount at this time, an optical rotation angle A that appears when the urine is propagated is calculated. Next, the control means 1 determines whether the calculated optical rotation angle A is a positive value or a negative value. If the calculated optical rotation angle A is a negative value, the optically active substance other than sugars such as proteins is abnormally excreted in urine. Is reported, the calculation result is discarded, and if the value is a positive value, the sugar concentration Cg is calculated according to (Equation 1), and 0 to 100 mg / d
l is (-), 100-150 mg / dl is (±), 150-3
It is converted to a division display symbol such as 00 mg / dl (+) and displayed on the notification means 2.

【0034】なお、本実施例では、尿中に蛋白質などの
異常排泄を判断する閾値を正値か負値に分ける方法で説
明したが、平均的な蛋白質やアミノ酸や糖などの尿への
平均排泄濃度を(式2)に当てはめて、平均的な尿中成
分で発現する平均旋光角度Amを算出し、この値を閾値
としてAmより大きいか小さいかを判定する方法も有効
である。
In this embodiment, the method of dividing the threshold for judging abnormal excretion of protein or the like into urine into positive and negative values has been described. However, the average protein, amino acid, sugar, etc. It is also effective to apply the excretion concentration to (Equation 2), calculate the average rotation angle Am that appears in the average urine component, and use this value as a threshold to determine whether it is larger or smaller than Am.

【0035】また、これらの各平均排泄濃度は、男女や
年齢などの個人差でも異なる事が知られており、検査に
先立って入力キーなどでこうした個人差情報を入力して
もらい、最適な閾値を使って判定する方法は更に有効で
ある。
It is also known that these average excretion concentrations differ depending on individual differences such as gender and age. Prior to the examination, the individual excretion concentration is input using an input key or the like to obtain an optimal threshold value. Is more effective.

【0036】更に、各旋光性物質の比旋光度αは、波長
により異なる波長特性を持っていることが知られてい
る。図2の説明では糖の比旋光度αgと蛋白質の比旋光
度αaがほぼ等しいケースを計算例として説明したが、
αaがαgよりも十分大きくなる900nm以下の波長
のレーザ光源を使用すれば、汎用用途のレーザ光源を適
用できる上、旋光角度Aが負値となるための尿蛋白濃度
の下限が下げられ、より判定感度を改善する上で有効で
ある。
Further, it is known that the specific optical rotation α of each optically rotating substance has different wavelength characteristics depending on the wavelength. In the description of FIG. 2, the case where the specific rotation αg of the sugar and the specific rotation αa of the protein are almost equal has been described as a calculation example.
If a laser light source having a wavelength of 900 nm or less where αa is sufficiently larger than αg can be used, a general-purpose laser light source can be applied, and the lower limit of the urine protein concentration for the optical rotation angle A to be a negative value can be reduced. This is effective in improving the determination sensitivity.

【0037】なお、この磁気的雰位法は、組立誤差が生
じにくい効果を有するものである。
The magnetic atmosphere method has an effect that an assembly error hardly occurs.

【0038】(実施例2)実施例2の発明を図4を参照
して説明する。本実施例は、旋光角度Aを検出するため
の構成が実施例1と異なるものであり、その他の動作は
実施例1と同様にできうるものである。
(Embodiment 2) The invention of Embodiment 2 will be described with reference to FIG. This embodiment is different from the first embodiment in the configuration for detecting the optical rotation angle A, and other operations can be performed in the same manner as in the first embodiment.

【0039】図4は、図1の尿検査装置を、光学的零位
法で構成する場合のブロック図である。図4の31〜3
3は破線3で囲んだ発光手段3の構成要素を示す一例で
あり、31はレーザ光源、33はレーザ光源31を点灯
させる発光回路、32はレーザ光源31から光の成分の
内、特定方向の偏光成分のみを通過させる偏光フィルタ
であり、ここでは垂直方向の偏光成分を通過させるよう
に配置する。図4の51、53、55は破線で囲んだ発
光手段5の構成要素を示す一例であり、51は尿を伝播
した光を受光するフォトダイオード、55は特定の偏光
方向の成分のみを通過させる検光フィルタを回転可能な
ように構成した回転検光フィルタであり、通過させる偏
光方向が、発光手段3内の偏光フィルタ23と互いに直
交するような初期位置に配置する。53はフォトダイオ
ード51の光量に応じた信号出力を電圧値に変換および
増幅して制御手段1に入力する受光回路である。
FIG. 4 is a block diagram in the case where the urine test apparatus of FIG. 1 is configured by the optical null method. 31 of FIG.
3 is an example showing the components of the light emitting means 3 surrounded by a broken line 3, 31 is a laser light source, 33 is a light emitting circuit for turning on the laser light source 31, 32 is a light component from the laser light source 31 in a specific direction. This is a polarizing filter that allows only a polarized light component to pass, and is arranged so as to pass a polarized light component in the vertical direction. In FIG. 4, reference numerals 51, 53, and 55 denote examples of components of the light-emitting means 5 surrounded by a broken line. Reference numeral 51 denotes a photodiode that receives light transmitted through urine, and 55 denotes only a component in a specific polarization direction. This is a rotation analysis filter configured to rotate the analysis filter, and is disposed at an initial position such that the polarization direction to be passed is orthogonal to the polarization filter 23 in the light emitting means 3. Reference numeral 53 denotes a light receiving circuit which converts and amplifies a signal output corresponding to the light amount of the photodiode 51 into a voltage value and inputs the voltage value to the control means 1.

【0040】62は、回転検光フィルタ55を回転さ
せ、その際の回転角度を検出して制御手段1に入力する
エンコーダ部を備えたモータ回路である。
Reference numeral 62 denotes a motor circuit having an encoder section for rotating the rotation detection filter 55, detecting a rotation angle at that time, and inputting the rotation angle to the control means 1.

【0041】以下に、図4の動作を説明する。尿溜り部
4に尿が充填され、ユーザの指示により尿検査が開始さ
れると、制御手段1は、発光回路33によりレーザ光源
31を点灯する。レーザ光源31からの光は、偏光フィ
ルタ32を通過して垂直偏光方向の成分のみが伝播す
る。この光は尿溜り部4内を伝播し、回転検光フィルタ
55を通過してフォトダイオード51に入射し、この際
の光量を受光回路53により電圧値に変換して制御手段
1に入力する。制御手段1は、モータ回路62により回
転検光フィルタ55を回転させ、受光回路53での受光
量が最小となる消光点を検出し、この時点の回転角度を
モータ回路62から入力する。本実施例の光学的零位法
の構成では、つまり、この時点の回転角度が、尿を通過
する際に発現された旋光角度Aと一致していることにな
る。
The operation of FIG. 4 will be described below. When urine is filled in the urine reservoir 4 and a urine test is started according to a user's instruction, the control means 1 turns on the laser light source 31 by the light emitting circuit 33. The light from the laser light source 31 passes through the polarization filter 32, and only the component in the vertical polarization direction propagates. This light propagates through the urine collecting section 4 and passes through the rotation detection filter 55 and enters the photodiode 51. The light amount at this time is converted into a voltage value by the light receiving circuit 53 and input to the control means 1. The control means 1 causes the motor circuit 62 to rotate the rotation detection filter 55, detects the extinction point at which the amount of light received by the light receiving circuit 53 is minimum, and inputs the rotation angle at this time from the motor circuit 62. In the configuration of the optical nulling method of this embodiment, that is, the rotation angle at this time coincides with the optical rotation angle A developed when passing through urine.

【0042】本実施例では、小型化を図ることができる
光学的零位法の構成で旋光角度Aを検出するものであ
り、これ以降の動作は、実施例1と同様にできうるもの
である。
In the present embodiment, the optical rotation angle A is detected by the configuration of the optical null method capable of reducing the size, and the subsequent operation can be performed in the same manner as in the first embodiment. .

【0043】なお、実施例1、2において、判定結果を
無効とした場合に、報知手段に再測定を促す旨を報知
し、再測地を促す時期を安静時、食後一定時間、空腹時
などとしてもよい。これにより、判定精度と使い勝手が
向上する。
In the first and second embodiments, when the determination result is invalidated, the notification means is notified to prompt re-measurement, and the timing for prompting the re-measurement is set at rest, a fixed time after a meal, or on an empty stomach. Is also good. Thereby, the determination accuracy and the usability are improved.

【0044】[0044]

【発明の効果】上記実施例から明らかなように、請求項
1の発明によれば、尿中を伝播した際に生じた旋光角度
Aが、予め設定した閾値以下または負値となる場合に、
該測定結果を無効判定機構を設けたものである。この判
定機能によって、代謝疾患や、疲労時や食事内容による
一時的な尿中への異常排泄による尿糖値の判定結果を向
上させることができる。
As is apparent from the above embodiment, according to the first aspect of the present invention, when the optical rotation angle A generated when propagating in urine is equal to or less than a predetermined threshold value or a negative value,
The measurement result is provided with an invalidity judgment mechanism. With this determination function, it is possible to improve the determination result of the urinary sugar level due to metabolic disease or temporary abnormal excretion in urine due to fatigue or meal contents.

【0045】また、請求項2の発明のように、予め設定
した閾値として、尿中の旋光性物質の平均濃度で発現す
る旋光角度の合算値として算出した旋光角度とすること
により、平均的な成分の尿との差が検出されやすくな
り、判定の精度をより向上できる。
Further, as described in the second aspect of the present invention, by setting a predetermined threshold value as an optical rotation angle calculated as a sum of optical rotation angles expressed at an average concentration of the optical rotation substance in urine, an average rotation angle can be obtained. The difference between the component and urine can be easily detected, and the accuracy of the determination can be further improved.

【0046】また、請求項3の発明のように、男女、年
齢、体格などの個人差により予め設定した閾値を変更す
ることにより、個人差に応じて最適な判定ができること
となる。
Further, by changing the threshold value set in advance according to individual differences such as gender, age, and physique as in the third aspect of the invention, it is possible to make an optimal determination according to individual differences.

【0047】また、請求項4の発明のように、伝播させ
る光の波長として、旋光性物質の旋光度が比較的大き
く、かつ汎用のレーザ光源を適用できる900nm以下
の波長を選ぶことにより、より閾値判定の精度を向上さ
せ、かつ商業上でもメリットのある構成が実現できる。
Further, as in the invention of claim 4, as the wavelength of the light to be propagated, a wavelength of 900 nm or less to which a general-purpose laser light source can be applied while the optical rotation of the optically rotating substance is relatively large is selected. It is possible to improve the accuracy of the threshold value determination and realize a commercially advantageous configuration.

【0048】また、請求項5の発明によれば、旋光角度
の測定を、磁気的零位法で構成したことにより、組立誤
差が生じにくい。
According to the fifth aspect of the present invention, since the optical rotation angle is measured by the magnetic null method, an assembly error hardly occurs.

【0049】また、請求項6の発明によれば、旋光角度
の測定を、光学的零位法で構成したことにより、小型化
を図ることができる。
According to the sixth aspect of the present invention, since the optical rotation angle is measured by the optical null method, the size can be reduced.

【0050】また、請求項7の発明によれば、報知手段
を設け、判定結果を無効とした場合に、前記報知手段に
より再測定を促すようにしたことにより、判定精度を向
上できる。
According to the seventh aspect of the present invention, the notifying means is provided, and when the judgment result is invalidated, the notifying means prompts the re-measurement, so that the judgment accuracy can be improved.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の実施例1の尿糖検査装置の構成を示す
ブロック図
FIG. 1 is a block diagram illustrating a configuration of a urine sugar testing device according to a first embodiment of the present invention.

【図2】本発明の実施例1における尿成分判定結果の一
例を示す図
FIG. 2 is a diagram illustrating an example of a urine component determination result according to the first embodiment of the present invention.

【図3】本発明の実施例1の尿糖検査装置の磁気的零位
法での構成を示すブロック図
FIG. 3 is a block diagram showing a configuration of the urine sugar testing apparatus according to the first embodiment of the present invention using a magnetic null method.

【図4】本発明の実施例2の尿糖検査装置の光学的零位
法での構成を示すブロック図
FIG. 4 is a block diagram showing a configuration of the urine sugar test apparatus according to the second embodiment of the present invention using an optical null method.

【符号の説明】[Explanation of symbols]

1 制御手段 2 報知手段 3 発光手段 4 尿溜り部 5 受光手段 6 旋光角度検出手段 REFERENCE SIGNS LIST 1 control means 2 notification means 3 light emitting means 4 urine reservoir 5 light receiving means 6 optical rotation angle detecting means

───────────────────────────────────────────────────── フロントページの続き (72)発明者 上田 実紀 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 (72)発明者 宮地 寿明 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 Fターム(参考) 2G045 AA16 CB03 DA31 FA11 FA29 GC30 2G059 AA01 BB13 CC16 EE01 EE05 GG01 GG04 HH01 JJ19 KK01 MM03 MM05 PP04  ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Miki Ueda 1006 Kazuma Kadoma, Osaka Pref. Matsushita Electric Industrial Co., Ltd. (72) Inventor Toshiaki Miyachi 1006 Odaka Kadoma Kadoma, Osaka Pref. Terms (reference) 2G045 AA16 CB03 DA31 FA11 FA29 GC30 2G059 AA01 BB13 CC16 EE01 EE05 GG01 GG04 HH01 JJ19 KK01 MM03 MM05 PP04

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 尿に光を伝播させた際に発現する旋光角
度を測定することによって前記尿中の糖濃度を測定する
尿検査装置において、前記尿中の糖成分により発現され
る旋光角度方向を正値とした場合に、前記尿中を伝播し
た際に生じた旋光角度が、予め設定した閾値以下負値と
なる場合に、該判定結果を無効とする尿検査装置。
1. A urine test apparatus for measuring a sugar concentration in urine by measuring an optical rotation angle generated when light is propagated in urine, wherein the optical rotation angle direction expressed by a sugar component in the urine is provided. A urine test apparatus that invalidates the determination result when the optical rotation angle generated when the light propagates in the urine is a negative value equal to or less than a predetermined threshold value when is a positive value.
【請求項2】 予め設定した閾値が、尿中の旋光性物質
の平均濃度で発現する旋光角度の合算値として算出した
旋光角度とする請求項1に記載の尿検査装置。
2. The urine test apparatus according to claim 1, wherein the preset threshold value is an optical rotation angle calculated as a sum of optical rotation angles that are expressed at an average concentration of the optical rotation substance in urine.
【請求項3】 男女、年齢、体格などの個人差により予
め設定した閾値を変更する請求項1または2に記載の尿
検査装置。
3. The urine test apparatus according to claim 1, wherein a preset threshold value is changed according to individual differences such as gender, age, and physique.
【請求項4】 伝播させる光の波長が、900nm以下
の波長である請求項1記載の尿検査装置。
4. The urine test apparatus according to claim 1, wherein the wavelength of the light to be propagated is a wavelength of 900 nm or less.
【請求項5】 旋光角度の測定を、磁気的零位法で構成
する請求項1記 載の尿検査装置。
5. The urine test apparatus according to claim 1, wherein the optical rotation angle is measured by a magnetic null method.
【請求項6】 旋光角度の測定を、光学的零位法で構成
する請求項1記載の尿検査装置。
6. The urine test apparatus according to claim 1, wherein the optical rotation angle is measured by an optical null method.
【請求項7】 報知手段を設け、判定結果を無効とした
場合に、前記報知手段により再測定を促すようにした請
求項1記載の尿検査装置。
7. The urine test apparatus according to claim 1, further comprising a notifying unit, wherein when the determination result is invalidated, the notifying unit prompts a re-measurement.
JP2000272803A 2000-09-08 2000-09-08 Urinalysis device Expired - Fee Related JP4507373B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000272803A JP4507373B2 (en) 2000-09-08 2000-09-08 Urinalysis device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000272803A JP4507373B2 (en) 2000-09-08 2000-09-08 Urinalysis device

Publications (2)

Publication Number Publication Date
JP2002082047A true JP2002082047A (en) 2002-03-22
JP4507373B2 JP4507373B2 (en) 2010-07-21

Family

ID=18758856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000272803A Expired - Fee Related JP4507373B2 (en) 2000-09-08 2000-09-08 Urinalysis device

Country Status (1)

Country Link
JP (1) JP4507373B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011058987A1 (en) * 2009-11-13 2011-05-19 株式会社堀場製作所 Polarimeter
JP2013174512A (en) * 2012-02-24 2013-09-05 Techno Medica Co Ltd Body fluid analyzer
JP2015194497A (en) * 2014-03-20 2015-11-05 富士ゼロックス株式会社 System for calculating concentration of optically active substance, and program
CN105814435A (en) * 2014-03-20 2016-07-27 富士施乐株式会社 Concentration calculation system of optically active substance, manufacturing method of concentration calculation system of optically active substance, and computer readable medium
KR101664683B1 (en) * 2015-04-15 2016-10-24 현대자동차주식회사 Adulterated fuel fill detecting device and method of vehicle

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6252434A (en) * 1985-08-30 1987-03-07 Shimadzu Corp Absorption photometric analytic method
JPH03100444A (en) * 1989-09-13 1991-04-25 Hitachi Ltd Device and method for automatic analysis for clinical examination
JPH0968523A (en) * 1995-08-31 1997-03-11 Brother Ind Ltd Biochemical substance measuring device
JPH09138231A (en) * 1995-11-16 1997-05-27 Matsushita Electric Ind Co Ltd Urinalytical method
JP2000214081A (en) * 1999-01-27 2000-08-04 Matsushita Electric Ind Co Ltd Measuring container and measuring apparatus for angle of rotation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6252434A (en) * 1985-08-30 1987-03-07 Shimadzu Corp Absorption photometric analytic method
JPH03100444A (en) * 1989-09-13 1991-04-25 Hitachi Ltd Device and method for automatic analysis for clinical examination
JPH0968523A (en) * 1995-08-31 1997-03-11 Brother Ind Ltd Biochemical substance measuring device
JPH09138231A (en) * 1995-11-16 1997-05-27 Matsushita Electric Ind Co Ltd Urinalytical method
JP2000214081A (en) * 1999-01-27 2000-08-04 Matsushita Electric Ind Co Ltd Measuring container and measuring apparatus for angle of rotation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011058987A1 (en) * 2009-11-13 2011-05-19 株式会社堀場製作所 Polarimeter
JP2013174512A (en) * 2012-02-24 2013-09-05 Techno Medica Co Ltd Body fluid analyzer
JP2015194497A (en) * 2014-03-20 2015-11-05 富士ゼロックス株式会社 System for calculating concentration of optically active substance, and program
CN105814435A (en) * 2014-03-20 2016-07-27 富士施乐株式会社 Concentration calculation system of optically active substance, manufacturing method of concentration calculation system of optically active substance, and computer readable medium
KR101664683B1 (en) * 2015-04-15 2016-10-24 현대자동차주식회사 Adulterated fuel fill detecting device and method of vehicle

Also Published As

Publication number Publication date
JP4507373B2 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
RU2050545C1 (en) Method and photometer for determining glucose contents in full blood
KR100219252B1 (en) Analytical system with means for detecting too small sample volumes
KR100540849B1 (en) A device for analyzing quantitatively material of a living creature
WO1997018470A1 (en) Method and apparatus for urinalysis, method of measuring optical rotation and polarimeter
JP2001515203A (en) Verifier for optical clinical assay systems
JPH1183745A (en) Inspection device for excremental component
EA012956B1 (en) System for rapid analysis of microbiological materials in liquid samples
EP1023583B1 (en) Method for measurement of blood substitutes
Kuenstner et al. Measurement of hemoglobin in unlysed blood by near-infrared spectroscopy
EP1738155B1 (en) Optical method to determine distribution of lipid particles in a sample
JP3308173B2 (en) Urine test method and urine test apparatus used therefor
JP4507373B2 (en) Urinalysis device
US20020042142A1 (en) Solution concentration measuring method and solution concentration measuring apparatus
JP4507372B2 (en) Urinalysis device
US7198955B1 (en) Method and apparatus for measurement of blood substitutes
JPH07301630A (en) Toilet bowl with urine component measuring device
JP2001004531A (en) Apparatus for inspecting urine
JP2007057317A (en) Automatic analyzer
Jacob et al. Automated rate-immunonephelometric determination of serum prealbumin (transthyretin).
Rovati et al. Determination of the concentrations of interferents in blood serum by use of a novel solid-state colorimeter
Shishkin et al. A portable reflectometric photometer for quantitative enzyme immunoassay
David Johnson et al. Fluorescence methods for measuring calcium affinity and calcium exchange with proteins
JPS6175238A (en) Biochemical measuring apparatus
Stein New fecal tests in the diagnosis of exocrine pancreatic insufficiency
JPH11271222A (en) Urine examination method

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070907

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20071012

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20091119

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091208

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100413

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100426

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 3

R151 Written notification of patent or utility model registration

Ref document number: 4507373

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140514

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees